欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
DE/V/0259/001
药品名称
Poulvac IB Primer
活性成分
avian infectious bronchitis virus 3.3 EID50/dose
剂型
Lyophilisate
上市许可持有人
Zoetis Deutschland GmbH Schellingstr. 1 10785 Berlin
参考成员国 - 产品名称
Germany (DE)
Poulvac IB Primer
互认成员国 - 产品名称
Latvia (LV)
Bulgaria (BG)
Romania (RO)
Slovenia (SI)
Portugal (PT)
Hungary (HU)
Czechia (CZ)
Cyprus (CY)
Austria (AT)
Greece (GR)
Croatia (HR)
Sweden (SE)
Belgium (BE)
Poulvac IB Primer
Netherlands (NL)
Denmark (DK)
Slovakia (SK)
United Kingdom (Northern Ireland) (XI)
Lithuania (LT)
Estonia (EE)
许可日期
2013/04/24
最近更新日期
2024/04/16
药物ATC编码
QI01AD07 avian infectious bronchitis virus
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
Full dossier - art 12.3 Dir 2001/82/EC
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
Final PL
|
WS2257 _ Annex b_WS2257 _ Annex b
Date of last change:2023/02/20
Final PL
|
WS2257 _ eAF_WS2257 _ eaf_maldi_tof_poulvac_range_signed
Date of last change:2023/02/20
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase